Pfizer

Pfizer

Pharmaceuticals
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

$156.2B

Market Cap • 11/20/2026

1942

(84 years)

Founded

1951

(75 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

S&P500 Participant

Index Composite • 2026

Valuation

P/B

1,8

P/S

2,5

P/EBITDA

14,5

P/OCF

11

P/FCF

13,3

P/E

39,1

BVPS

15,6

EPS

0,7

Market Cap

Market Cap

156,2B

EV

204,9B

EV/Revenue

3,2

EV/EBITDA

19

EV/EBIT

48,1

Payout

Dividend Per Share

1,7

Dividend Yield

6,3%

Buyback Yield

0%

Total Yield

6,3%

Dividend Yield 5Y

6,5%

Payout

242,8%

Retained Earnings

115,3B

Profitability

Gross Margin

73,4%

EBITDA Margin

16,9%

EBIT Margin

6,7%

Net Margin

6,4%

D&A/EBITDA

43,9%

R&D/Revenue

19,7%

Capex/Revenue

3,8%

Capex/D&A

36,7%

Capex/OCF

16,8%

SBC/OCF

7,8%

% PPE

9,3%

% Goodwill

34,9%

ROE

4,5%

ROIC

2,5%

Growth

CAGR Revenue 5Y

-1,6%

CAGR Op. Income 5Y

-32%

CAGR Net Income 5Y

-32,6%

CAGR EPS 5Y

-27,3%

CAGR OCF 5Y

-15,2%

Leverage

N.D./EBITDA

4,5

Debt/Equity

0%

Current Ratio

1,4

Quick Ratio

0,9

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium